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Three novel canine papillomaviruses support taxonomic clade
formation
Abstract
More than 100 human papillomaviruses (HPVs) have been identified and had their whole genomes
sequenced. Most of these HPVs can be classified into three distinct genera, the alpha-, beta- and
gamma-papillomaviruses (PVs). Of note, only one or a small number of PVs have been identified for
each individual animal species. However, four canine PVs (CPVs) (COPV, CPV2, CPV3 and CPV4)
have been described and their entire genomic sequences have been published. Based on their sequence
similarities, they belong to three distinct clades. In the present study, circular viral DNA was amplified
from three dogs showing signs of pigmented plaques, endophytic papilloma or in situ squamous cell
carcinoma. Analysis of the DNA sequences suggested that these are three novel viruses (CPV5, CPV6
and CPV7) whose genomes comprise all the conserved sequence elements of known PVs. The genomes
of these seven CPVs were compared in order properly classify them. Interestingly, phylogenetic
analyses, as well as pairwise sequence alignments of the putative amino acid sequences, revealed that
CPV5 grouped well with CPV3 and CPV4, whereas CPV7 grouped with CPV2 but neither group fitted
with other classified PVs. However, CPV6 grouped with COPV, a lambda-PV. Based on this evidence,
allocation of CPVs into three distinct clades could therefore be supported. Thus, similar to HPVs, it
might be that the known and currently unknown CPVs are related and form just a few clades or genera.
  
Three novel canine papillomaviruses support 1 
taxonomic clade formation  2 
 3 
 4 
Christian E. Lange1,2, Kurt Tobler2, Mathias Ackermann2, Lucia Panakova3, Keith L. 5 
Thoday4, Claude Favrot1 6 
 7 
1 Dermatology Department, Clinic for Small Animal internal Medicine, Vetsuisse 8 
Faculty, Winterthurerstrasse 260, CH-8057 Zurich, Switzerland  9 
2 Institute of Virology, Vetsuisse Faculty, Winterthurerstrasse 266a, CH-8057 Zurich, 10 
Switzerland 11 
3 Small Animal Hospital, Am Schonenwald, D-55765 Birkenfeld, Germany 12 
4 The Royal (Dick) School of Veterinary Studies, Dermatology Unit, Division of 13 
Veterinary Clinical Sciences, The University of Edinburgh, ROSLIN Midlothian 14 
EH25 9RG Scotland, UK 15 
 16 
Correspondence 17 
Christian E. Lange 18 
Tel.: +41446358387 19 
clange@vetclinics.uzh.ch 20 
 21 
The GenBank accession numbers for the sequences reported in this paper are 22 
FJ492742 - FJ492744 23 
24 
  
 24 
Summary 25 
More than hundred human papillomaviruses (PVs) have been identified and their 26 
whole genomes sequenced. Most of these human PVs can be classified into three 27 
distinct genera, the alpha- beta-, and gamma-PVs. Of note, only one or a small 28 
number of PVs have been identified for each individual animal species. Yet, four 29 
canine papillomaviruses (COPV, CPV2, CPV3, and CPV4) have been described and 30 
their entire genomic sequences published. Based on their sequence similarities, they 31 
belong to three distinct clades. 32 
In the present study, circular viral DNA was amplified from three dogs showing signs 33 
of pigmented plaques, of endophytic papilloma or of in situ squamous cell carcinoma. 34 
Analysis of the DNA sequences suggested that three novel viruses (CPV5, CPV6, and 35 
CPV7) had been detected; whose genomes comprise all the conserved sequence 36 
elements of known PVs. 37 
The genomes of these seven canine PVs were compared in order to help classify them 38 
properly. Interestingly, phylogenetic analyses as well as pairwise sequence alignments 39 
of the putative amino acid sequences revealed that CPV5 grouped well with CPV3 40 
and CPV4, whereas CPV7 grouped with CPV2 but neither group fit in with other 41 
classified PVs. Yet, CPV6 grouped with COPV, a lambda-PV. Based on this 42 
evidence, allocation of CPVs into so far three distinct clades could therefore be 43 
supported. Thus similarly to human PVs, it might be that the known and yet unknown 44 
canine PVs are related and form just a few clades or genera. 45 
46 
  
 46 
Introduction 47 
Papillomaviruses (PVs) are small, non-enveloped, double-stranded DNA viruses that 48 
have a tropism for the skin and for mucosal membranes (Howley & Lowy, 2007). 49 
They have been found to be innocuous inhabitants of the healthy skin, but in addition, 50 
are associated with various neoplastic diseases (Howley & Lowy, 2007). A high 51 
oncogenic potential of several PV types has been demonstrated; others are known to 52 
be less oncogenic, facultative pathogenic or believed to be apathogenic (Antonsson et 53 
al., 2000, Antonsson & Hansson, 2002, Burd, 2003, Munoz et al., 2003). 54 
A categorization of the PVs based on their oncogenic potential has been suggested, 55 
grouping the known viruses into high-, intermediate- and low-risk PVs (Lorincz et al., 56 
1992 and Bosch et al., 1995). This grouping is only partly reflected in the genomic 57 
characterization of the PVs. The viruses combined in one genus based on the 58 
nucleotide sequence of the L1 open reading frame (ORF) may share very distinct 59 
features, but the biological effects of these can differ significantly (de Villiers et al., 60 
2004). Knowledge of the phylogenetics, the genomic organisation and the biological 61 
effects taken together may be the best way of characterizing PVs. 62 
 63 
So far more than one hundred human PVs (HPVs) have been isolated, cloned and 64 
sequenced completely and many more partially. They group into the genera alpha-, 65 
beta-, gamma-, mu- and nu-PV. Not only HPVs but also a growing number of animal 66 
PVs have been detected in lesional and in healthy skin of mammals, birds and even 67 
reptiles in recent years. It would be anticipated that, in addition to humans, each 68 
animal species might carry a large set of PV types. So far, for most animal species 69 
only one or a very small number of PVs have been completely sequenced. In very few 70 
animal species, viruses belonging to different genera have been identified. A 71 
categorization of these frequently single standing viruses is often difficult or currently 72 
impossible, as close relatives are usually missing. 73 
A total of four virus genomes obtained from dogs has been published to date (Delius 74 
et al., 1994, Tobler et al., 2006, Tobler et al., 2008, Yuan et al., 2007). They seem to 75 
belong to three different clades of which only one (lambda-PVs) has been named. The 76 
possible relevance of these clades is not yet clear and their characteristics are, at 77 
present, vague. 78 
 79 
In this study we sequenced the DNA of three new canine papillomaviruses (CPVs) 80 
extracted from three clinically affected dogs, one of them suffering from pigmented 81 
plaques, one from an inverted papilloma and one from an in situ squamous cell 82 
carcinoma (SCC). Rolling cycle amplification, restriction enzyme analysis, genomic 83 
cloning and primer walking sequencing were applied. The new viruses CPV5, CPV6 84 
and CPV7 were compared with the other known CPVs in terms of their genomes and 85 
genomic features, their phylogenetics and the corresponding lesions. A clear grouping 86 
of the new viruses into the three proposed clades was possible and some additional 87 
characteristics could also be identified. 88 
 89 
  
Methods 90 
Animals and samples 91 
Dog one was presented at a small animal hospital in Birkenfeld, Germany with 92 
numerous pigmented and partially hyperkeratotic macules, papules, patches and 93 
nodules distributed on the whole body. 94 
Dog two was presented at the veterinary teaching hospital in Zurich, Switzerland with 95 
a large plaque on the ventral throat. This plaque consisted of numerous dome-shaped 96 
papules with a central plug of keratin.  97 
Dog three was a five-year old, male, trailhound presented to the veterinary teaching 98 
hospital in Edinburgh, Scotland with hyperkeratotic plaques on the concave faces of 99 
the pinnae. 100 
In order to make a diagnosis, 6 mm skin biopsies were taken and sent to three 101 
different histopathology laboratories, where they were processed routinely 102 
(haematoxylin & eosin staining). Additionally samples were frozen immediately after 103 
excision and for virological analysis sent to the Dermatology Unit of the Vetsuisse 104 
Faculty in Zurich, Switzerland. Histological analyses revealed these samples 105 
corresponded to canine pigmented plaques, inverted papillomas and in situ SCC, 106 
respectively. 107 
 108 
Amplification and cloning of genomes 109 
Total DNA from 25 mg tissue samples of the three dogs was isolated by using a 110 
DNeasy extraction kit (Qiagen) according to the manufacturer's recommendations. 111 
DNA (1 µl) was used for rolling circle amplification (Rector et al., 2004), using a 112 
TempliPhi Amplification kit (General Electrics Biosciences). The protocol supplied 113 
by the manufacturer was used, with slight modifications. Additionally 1µl of 10 mM 114 
dNTPs were added and the reaction time was prolonged to 16 h at 30 °C. Amplified 115 
DNA was digested with different restriction enzymes to compare the restriction 116 
patterns and to identify possible single cutters. Amplified DNA was cloned into 117 
pBluescript II-KS+ (Stratagene) using standard procedures. In case one the XbaI and 118 
ClaI sites, in case two the EagI and SpeI sites and in case three the HinDIII and 119 
BamHI sites were used initially. The ClaI, EagI and HinDIII clones respectively were 120 
identified to contain the complete genomes. 121 
 122 
Sequence analysis 123 
The nucleotide sequence of cloned DNA and precipitated rolling circle amplification 124 
product was determined commercially (Microsynth) by cycle sequencing using an 125 
ABI 377 sequencer (Applied Biosystems). The primary sequences were assembled 126 
using Contigexpress (Vector NTI Informax). Besides the CPVs 43 PVs covering all 127 
genera and including various unclassified PVs were chosen for the pylogenetic 128 
analysis. Some PVs associated with cutaneous lesions in humans were also included. 129 
Multiple sequence alignments of the L1 protein sequences were done with Mafft 130 
(version 6.611b: Blossum 62 matrix; (Katoh & Toh, 2008)). Aligned cDNA 131 
sequences were produced by aligning the coding sequences with the corresponding 132 
aligned amino acid sequences. Bayesian phylogeny was estimated with MrBayes 133 
(version 3.1.2: Markov Chain Monte Carlo (MCMC) with GTR substitution matrix, 134 
  
variable gamma rates, 2 runs with 4 chains of 1‘000‘000 generations; (Ronquist & 135 
Huelsenbeck, 2003)). Evaluation of the MCMC and final refinements of the tree were 136 
performed with Beast (version 1.4.8; (Drummond & Rambaut, 2007)). 137 
The nucleotide sequence data of CPV5, CPV6 and CPV7 were deposited in GenBank 138 
under accession nos. FJ492742 - FJ492744. 139 
 140 
Results 141 
Genome and Open Reading Frames 142 
PVs have a characteristic genome size being roughly around eight kilobasepairs (kb) 143 
and a circular genomic organization containing usually six to eight open reading 144 
frames (ORFs) as well as one or two non-coding-regions (NCRs) (Howley & Lowy, 145 
2007). To compare the genomes of the seven CPVs, they were all annotated in the 146 
same way. The genome sizes of the CPVs vary more than 800 bp (Fig. 1), ranging 147 
from 7742 basepairs (bp) of CPV4’s genome to 8607 bp of COPV, which is still the 148 
largest described PV genome. A comparative analysis of alpha, beta, and gamma 149 
HPV genome sizes showed a significant correlation of genome length and genus (Fig. 150 
S1). In all CPV genomes, seven characteristic ORFs can be identified (Fig. 1). While 151 
the ORFs of the late genes appear to be quite conserved in terms of size, certain 152 
differences can be observed among the early genes and the NCRs (Tab. 1). Most 153 
prominent is the typical lambda-PV pattern with a very large second NCR (NCR2) 154 
and rather small E2 and E4 ORFs, which is present in COPV and CPV6. In case of 155 
CPV3, CPV4 and CPV5, the NCR2 is with around 200 nucleotides small while the 156 
NCR2 of COPV or CPV6 each is at least twice as long. According to the genome size 157 
and the genome organization the two viruses COPV and CPV6, the two viruses CPV2 158 
and CPV7 and the viruses CPV3, CPV4 and CPV5 might be grouped together. 159 
 160 
 161 
Characteristic motifs 162 
Besides the ORFs, several characteristic features on the nucleotide and amino acid 163 
level are known, which are predicted to play a role in the PV life cycle (Androphy et 164 
al., 1987, Howley & Lowy, 2007, Münger et al., 2004, Wilson et al., 2002). All CPV 165 
sequences were scanned to identify these putative sites and the analysis revealed 166 
typical features in the genomes of all seven (Tab. S1). The GC content of the entire 167 
genomes are 40-53%. Whereas the clade consisting of CPV3, CPV4 and CPV5 show 168 
the highest namely 51%, 53% and 50%, respectively. Besides transcription factor 169 
binding sites as for SP1 and NF1 and the TATA signals, the sequence elements for 170 
PV DNA replication were found in all seven viral genomes. In particular, a dyad 171 
symmetry repeat flanked by two E2 binding site is present on each genomic sequence 172 
within the NCR1. Examination of the putative protein sequences reveal an ATP-173 
dependent helicase motif located in each E1 and two or one metal-binding motifs in 174 
E6 and E7, respectively.  175 
 176 
Sequence analysis and comparison 177 
In order to evaluate the possible classification of the three newly-recognized canine 178 
PVs, phylogeny based on the L1 sequences was determined. Amino acid sequences of 179 
  
fifty L1 proteins, including these from the newly recognized three canine PVs, were 180 
aligned, the alignment was back-translated into the nucleotide sequences and used to 181 
infer the phylogeny of the fifty PVs (Fig. 2). Based on the resulting tree, the three 182 
viruses CPV3, CPV4, and CPV5 are located on one clades of the tree close to BPV1 183 
and OvPV1 (delta-PV) and BPV5 (epsilon-PV) and EcPV1 (zeta-PV). Likewise, 184 
CPV7 neighbors to CPV2 in proximity to HPV4 and HPV50 (gamma-PV) and CPV6 185 
neighbors to FdPV1 and COPV (lambda-PV). In conclusion, each of the three newly 186 
recognized canine PVs is related to one previously described canine PV.  187 
In order to further investigate the relatedness of the canine PVs, pairwise alignments 188 
were performed for each individual protein sequence of each virus against all other 189 
viruses (Tab. 2). The most conserved amino acid sequences are L1 (46-82 %) and E1 190 
(39-81 %). Other protein sequences as the E2 (24-65%) and L2 (29-78%) are in 191 
general less conserved among the canine PVs. The intra-clade comparisons of the E1 192 
proteins reveal 65-81% identity whereas the inter-clade only around 40% (39-44%) 193 
identity. Similarly, intra-clade comparisons of the L1 proteins reveal 70-82% identity 194 
whereas the inter-clade only around 50% (46-54%) identity. Throughout most protein 195 
alignments, CPV3, CPV4, and CPV5 reveal higher intra-clade identities as the other 196 
two proposed clades COPV and CPV6 or CPV2 and CPV7. The E2 of CPV4 is less 197 
identical to the one of CPV3 and CPV5 than COPV’s to CPV6’s.  Likewise, the L1 of 198 
CPV4 is less identical to the one of CPV3 and CPV5 than COPV’s to CPV6’s or 199 
CPV2’s to CPV7’s. In conclusion, the pairwise amino acid alignments support the 200 
classification of the canine PVs into three clades.  201 
 202 
Associated clinical conditions 203 
The association of PVs with certain clinical signs is of special interest. The 204 
corresponding information from the published and the novel cases was assembled and 205 
analyzed (Tab. 3). CPV3, CPV4 and CPV5 appear similar, as they are all associated 206 
with pigmented plaques that are of a persistent character. COPV and CPV6 were 207 
mainly found associated with self-regressing lesions. A certain grouping of viruses in 208 
terms of their associated clinical conditions seems to be present. 209 
 210 
 211 
Discussion 212 
PVs are known to exist in a relatively large genetic variety in humans, but so far the 213 
whole genomes of only four CPVs grouping into three distinct clades have been 214 
published. The latter finding supported the hypothesis that there might be a broad 215 
variety of CPVs as well. The genomic sequences, features, phylogenetics and disease-216 
associations of these four CPVs were here compared with those of three novel PVs in 217 
order to get a better overall picture of CPVs and their characteristics. Not only the 218 
typical lambda-PV features such as a large NCR2 in case of COPV and CPV6 were 219 
identified but also possible characteristics of the two other proposed CPV clades. 220 
 221 
The size of the CPV genomes was found to differ among the three proposed CPV 222 
clades. Those of the lambda-PVs were, as lambda-PVs are in general, the longest. The 223 
sequences of CPV2 and CPV7 were still long but clearly shorter than the lambda-PVs. 224 
The shortest, and in terms of length least varying genomic sequences, were found 225 
among the clade of CPV3. This appears to be a parallel to HPVs of the genera alpha, 226 
  
beta and gamma (Fig S2). Size trends could also be seen in all the coding and non-227 
coding regions of the CPV genomes with the most prominent difference in case of the 228 
lambda-PVs where the NCR2 was longest while E2 and E4 were shortest. It is not 229 
clear what kind of biological effects may be associated with these, in several cases 230 
significant, size differences of the genomes and ORFs. The differences, nevertheless, 231 
seem to be mainly clade specific, in analogy to findings in HPVs. Some trends 232 
recognized in HPVs nevertheless do not seem to be present in CPVs, namely the 233 
association of low GC content and a small E2 ORF with a high risk to develop 234 
tumors. As only very few members in each proposed CPV clade have been 235 
recognized, these trends remain uncertain and need to be reconsidered whenever new 236 
viruses grouping into these clades are discovered. 237 
 238 
The phylogenetic analysis of the CPVs in comparison with other PVs grouped the 239 
seven CPVs into three proposed clades. The positions of the clades could be 240 
confirmed, but the posterior probability support of the Bayesian phylogeny of the 241 
canine clades remains limited, as not many closely related PVs are yet known. This 242 
finding nevertheless further supports the hypothesis that animals, like humans, harbor 243 
their own set of PVs grouping into different genera with different characteristics. This 244 
hypothesis previously arose from the discovery of several bovine PVs (Campo et al., 245 
1981 and Jarrett et al., 1984, Claus et al., 2008, Hatama et al., 2008, Ogawa et al., 246 
2007, Tomita et al., 2007) and recently from the discovery of some CPVs (Tobler et 247 
al., 2006, Tobler et al., 2008, Yuan et al., 2007). The clade including CVP3, CPV4 248 
and CPV5 as well as the clade including CPV2 and CPV7 should consequently be 249 
regarded as genera even though they might temporarily remain unnamed. It can be 250 
anticipated that several CPVs, which might be dicovered will group into these three 251 
proposed genera. The discovery of CPVs grouping into other possibly new clades can 252 
nevertheless also be expected, since fragments of PVs, which may not fit into the 253 
present clades, were previously found in canine lesions (Zaugg et al., 2005). 254 
 255 
Phylogenetic classifications of human PV only partially correlate with clinical 256 
presentation (Howley & Lowy, 2007). Similarly, the putative classification of canine 257 
PVs (Tab. 3) does not unanimously link with the clinical consequences of infection. 258 
Nevertheless, some features seem to be characteristic for some clades. CPV3, CPV4 259 
and CPV5 were extracted from dogs suffering from persisting pigmented plaques and 260 
might be associated with these signs of disease. COPV and CPV6 might by associated 261 
with transient endophytic or exophytic proliferation but also with asymptomatic 262 
infection (unpublished data). 263 
 264 
In conclusion, the genomic analysis of three novel CPV propose their classification 265 
into three distinct genera. The putative characteristics of these genera may be applied 266 
to classify other yet unknown CPVs. Their sequences and biological properties might 267 
disclose the true nature of PV infections in dogs. 268 
 269 
Acknowledgments 270 
 271 
We thank Marco Franchini University of Zurich, Switzerland for support on statistical 272 
questions and Hugo Stocker ETH Zurich, Switzerland for editorial advice. This study 273 
was funded by the Krebliga Switzerland. 274 
  
 275 
References 276 
 277 
Androphy, E. J., Lowy, D. R. & Schiller, J. T. (1987). Bovine papillomavirus E2 278 
trans-activating gene product binds to specific sites in papillomavirus DNA. 279 
Nature 325, 70-3. 280 
Antonsson, A., Forslund, O., Ekberg, H., Sterner, G. & Hansson, B. G. (2000). The 281 
ubiquity and impressive genomic diversity of human papillomavirus suggest a 282 
commensalic nature of the viruses. Journal  of Virology 74, 11636-11641. 283 
Antonsson, A. & Hansson, B. G. (2002). Healthy skin of many animal species 284 
harbours papillomaviruses which are closely related to their human 285 
counterparts. J Virol 76, 12537-42. 286 
Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., 287 
Schiffman, M. H., Moreno, V., Kurman, R. & Shah, K. V. (1995). Prevalence 288 
of human papillomavirus in cervical cancer: a worldwide perspective. 289 
International biological study on cervical cancer (IBSCC) Study Group. J Natl 290 
Cancer Inst 87, 796-802. 291 
Burd, E. M. (2003). Human papillomavirus and cervical cancer. Clin Microbiol Rev 292 
16, 1-17. 293 
Campo, M. S., Moar, M. H., Laird, H. M. & Jarrett, W. F. (1981). Molecular 294 
heterogeneity and lesion site specificity of cutaneous bovine papillomaviruses. 295 
Virology 113, 323-35. 296 
Claus, M. P., Lunardi, M., Alfieri, A. F., Ferracin, L. M., Fungaro, M. H. & Alfieri, 297 
A. A. (2008). Identification of unreported putative new bovine papillomavirus 298 
types in Brazilian cattle herds. Vet Microbiol 132, 396-401. 299 
Delius, H., Van Ranst, M. A., Jenson, A. B., zur Hausen, H. & Sundberg, J. P. (1994). 300 
Canine oral papillomavirus genomic sequence: a unique 1.5-kb intervening 301 
sequence between the E2 and L2 open reading frames. Virology 204, 447-52. 302 
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U. & zur Hausen, H. 303 
(2004). Classification of papillomaviruses. Virology 324, 17-27. 304 
Drummond, A. J. & Rambaut, A. (2007). BEAST: Bayesian evolutionary analysis by 305 
sampling trees. BMC Evol Biol 7, 214. 306 
Ghim, S., Newsome, J., Bell, J., Sundberg, J. P., Schlegel, R. & Jenson, A. B. (2000). 307 
Spontaneously regressing oral papillomas induce systemic antibodies that 308 
neutralize canine oral papillomavirus. Exp Mol Pathol 68, 147-51. 309 
Goldschmidt, M. H., Kennedy, J. S., Kennedy, D. R., Yuan, H., Holt, D. E., Casal, M. 310 
L., Traas, A. M., Mauldin, E. A., Moore, P. F., Henthorn, P. S., Hartnett, B. J., 311 
Weinberg, K. I., Schlegel, R. & Felsburg, P. J. (2006). Severe papillomavirus 312 
infection progressing to metastatic squamous cell carcinoma in bone marrow-313 
transplanted X-linked SCID dogs. J Virol 80, 6621-8. 314 
Hatama, S., Nobumoto, K. & Kanno, T. (2008). Genomic and phylogenetic analysis 315 
of two novel bovine papillomaviruses, BPV-9 and BPV-10. J Gen Virol 89, 316 
158-63. 317 
Howley, P. M. & Lowy, D. R. (2007). Papillomaviruses. In Fields Virology, 5th edn, 318 
pp. 2299-2354. Edited by D. M. Knipe & P. M. Howley. Philadelphia: 319 
Lippincott Williams & Wilkins. 320 
Jarrett, W. F., Campo, M. S., O'Neil, B. W., Laird, H. M. & Coggins, L. W. (1984). A 321 
novel bovine papillomavirus (BPV-6) causing true epithelial papillomas of the 322 
mammary gland skin: a member of a proposed new BPV subgroup. Virology 323 
136, 255-64. 324 
  
Katoh, K. & Toh, H. (2008). Recent developments in the MAFFT multiple sequence  325 
alignment program. Brief Bioinform 9, 286-98. 326 
Lange, C. E., Tobler, K., Favrot, C., Muller, M., Nothling, J. O. & Ackermann, M. 327 
(2009). Detection of antibodies against epidermodysplasia verruciformis-328 
associated canine papillomavirus 3 in sera of dogs from Europe and Africa by 329 
enzyme-linked immunosorbent assay. Clin Vaccine Immunol 16, 66-72. 330 
Lorincz, A. T., Reid, R., Jenson, A. B., Greenberg, M. D., Lancaster, W. & Kurman, 331 
R. J. (1992). Human papillomavirus infection of the cervix: relative risk 332 
associations of 15 common anogenital types. Obstet Gynecol 79, 328-37. 333 
M`Fadyean, J. & Hobday, E. (1898). Note on the experimental transmission of warts 334 
in the dog. J. Comp. Path. & Therap., 11, 341-44 335 
Munoz, N., Bosch, F. X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K. V., 336 
Snijders, P. J. & Meijer, C. J. (2003). Epidemiologic classification of human 337 
papillomavirus types associated with cervical cancer. N Engl J Med 348, 518-338 
27. 339 
Münger, K., Baldwin A, Hayakawa, H., Nguyen, C. L., Owens, M., Grace, M. & Huh, 340 
K. (2004). Mechanisms of Human Papillomavirus-Induced Oncogenesis. J. 341 
Virol. 78, 11451-11460. 342 
Narama, I., Kobayashi, Y., Yamagami, T., Ozaki, K. & Ueda, Y. (2005). Pigmented 343 
cutaneous papillomatosis (pigmented epidermal nevus) in three pug dogs; 344 
histopathology, electron microscopy and analysis of viral DNA by the 345 
polymerase chain reaction. J Comp Pathol 132, 132-8. 346 
Nicholls, P. K. & Stanley, M. A. (1999). Canine papillomavirus - A centenary review. 347 
J Comp Pathol 120, 219-233. 348 
Ogawa, T., Tomita, Y., Okada, M. & Shirasawa, H. (2007). Complete genome and 349 
phylogenetic position of bovine papillomavirus type 7. J Gen Virol 88, 1934-350 
8. 351 
Rector, A., Tachezy, R. & Van Ranst, M. A. (2004). Sequence independant strategy 352 
for detection and cloning of circular DNA virus genome by using multiply 353 
primed rolling circle amplification. J. Virol. 78, 1993-1998. 354 
Ronquist, F. & Huelsenbeck, J. P. (2003). MrBayes 3: Bayesian phylogenetic 355 
inference under mixed models. Bioinformatics 19, 1572-4. 356 
Sundberg, J. P., Smith, E. K., Herron, A. J., Jenson, A. B., Burk, R. D. & Van Ranst, 357 
M. (1994). Involvement of canine oral papillomavirus in generalized oral and 358 
cutaneous verrucosis in a Chinese Shar Pei dog. Vet Pathol 31, 183-7. 359 
Tanabe, C., Kano, R., Nagata, M., Nakamura, Y., Watanabe, S. & Hasegawa, A. 360 
(2000). Molecular characteristics of cutaneous papillomavirus from the canine 361 
pigmented epidermal nevus. J Vet Med Sci 62, 1189-92. 362 
Tobler, K., Favrot, C., Nespeca, G. & Ackermann, M. (2006). Detection of the 363 
prototype of a potential novel genus in the family Papillomaviridae in 364 
association with canine epidermodysplasia verruciformis. J Gen Virol 87, 365 
3551-7. 366 
Tobler, K., Lange, C., Carlotti, D. N., Ackermann, M. & Favrot, C. (2008). Detection 367 
of a novel papillomavirus in pigmented plaques of four pugs. Vet Dermatol 19, 368 
21-5. 369 
Tomita, Y., Literak, I., Ogawa, T., Jin, Z. & Shirasawa, H. (2007). Complete genomes 370 
and phylogenetic positions of bovine papillomavirus type 8 and a variant type 371 
from a European bison. Virus Genes 35, 243-9. 372 
Wilson, V. G., West, M., Woytek, K. & Rangasamy, D. (2002). Papillomavirus E1 373 
proteins: form, function, and features. Virus Genes 24, 275-90. 374 
  
Yuan, H., Ghim, S., Newsome, J., Apolinario, T., Olcese, V., Martin, M., Delius, H., 375 
Felsburg, P., Jenson, B. & Schlegel, R. (2007). An epidermotropic canine 376 
papillomavirus with malignant potential contains an E5 gene and establishes a 377 
unique genus. Virology 359, 28-36. 378 
Zaugg, N., Nespeca, G., Hauser, B., Ackermann, M. & Favrot, C. (2005). Detection 379 
of novel papillomaviruses in canine mucosal, cutaneous and in situ squamous 380 
cell carcinomas. Vet Dermatol 16, 290-8. 381 
 382 
 383 
Table 1 384 
Size and positions of predicted ORFs and NCRs 385 
 386 
ORF COPV CPV2 CPV3 CPV4 CPV5 CPV6 CPV7 
E6 432 
(364-795) 
405 
(496-900) 
453 
(570-1022) 
453 
(560-1012) 
456 
(563-1018) 
405 
(388-792) 
414 
(488-901) 
E7 291 
(795-1085) 
294 
(906-1199) 
315 
(970-1284) 
297 
(975-1271) 
300 
(981-1280) 
291 
(792-1082) 
294 
(906-1199) 
E1 1791 
(1078-2868) 
1821 
(1186-3006) 
1884 
(1277-3160) 
1887 
(1264-3150) 
1887 
(1273-3159) 
1791 
(1075-2883) 
1815 
(1186-3000) 
E2 1191 
(2777-3967) 
1593 
(2948-4540) 
1449 
(3105-4553) 
1461 
(3095-4555) 
1467 
(3104-4570) 
1191 
(2828-3991) 
1512 
(2842-4453) 
E4 348 
(3378-3725) 
1047 
(3249-4295) 
645 
(3670-4314) 
705 
(3423-4127) 
762 
(3570-4331) 
348 
(3405-3755) 
732 
(3480-4211) 
L2 1539 
(5550-7088) 
1524 
(5053-6576) 
1515 
(4764-6278) 
1524 
(4700-6223) 
1515 
(4769-6283) 
1539 
(5192-6724) 
1530 
(4893-6422) 
L1 1509 
(7099-8607) 
1509 
(6593-8101) 
1500 
(6302-7801) 
1497 
(6246-7742) 
1503 
(6308-7810) 
1509 
(6737-8242) 
1512 
(6444-7955) 
NCR1 363 
(1-363) 
495 
(1-495) 
569 
(1-569) 
559 
(1-559) 
562 
(1-562) 
387 
(1-387) 
487 
(1-487) 
NCR2 1582 
(3968-5549) 
512 
(4541-5052) 
210 
(4554-4763) 
144 
(4556-4699) 
198 
(4571-4768) 
1200 
(3992-5191) 
439 
(4454-4892) 
 387 
 388 
389 
  
Table 2 389 
Comparison of the ORFs on the protein level indicated as percentage identities 390 
E1 391 
 392 
 
 
COPV CPV2 CPV3 CPV4 CPV5 CPV6 CPV7 
COPV - 45 42 41 42 65 42 
CPV 2 24 - 42 40 40 44 70 
CPV 3 33 27 - 74 81 44 40 
CPV 4 33 26 54 - 76 44 39 
CPV 5 34 26 64 53 - 44 39 
CPV 6 65 26 36 35 34 - 40 
CPV 7 30 52 30 28 29 32 - 
 393 
E2 394 
 395 
E6 396 
 397 
 
 
COPV CPV2 CPV3 CPV4 CPV5 CPV6 CPV7 
COPV - 32 25 28 23 43 34 
CPV 2 31 - 31 34 30 39 54 
CPV 3 40 22 - 62 67 29 29 
CPV 4 46 25 78 - 56 33 31 
CPV 5 45 28 80 80 - 32 28 
CPV 6 59 35 31 40 41 - 42 
CPV 7 33 72 20 25 29 35 - 
 398 
E7 399 
 400 
L1 401 
 402 
 COPV CPV2 CPV3 CPV4 CPV5 CPV6 CPV7 
COPV - 49 52 54 53 72 50 
CPV 2 30 - 46 49 50 48 73 
CPV 3 34 31 - 71 82 51 46 
CPV 4 34 31 66 - 70 51 48 
CPV 5 35 31 78 66 - 52 48 
CPV 6 62 28 35 33 34 - 48 
CPV 7 29 64 30 29 30 28 - 
 403 
L2 404 
405 
  
Table 3  405 
Canine PVs and clinical correspondents 406 
 407 
Virus Genus Clinical signs Previous Reports 
(selection) 
COPV λ Oral papillomas, inverted 
papillomas, invasive SCC, 
asymptomatic infections 
 (M’Fadyean and Hobday, 
1898), (Sundberg et al., 
1994), (Delius et al., 1994) 
(Nicholls & Stanley, 1999) 
(Ghim et al., 2000) (Lange 
et al., 2009)  
CPV2 * Inverted papillomas, exophytic 
warts 
(Goldschmidt et al., 2006) 
(Yuan et al., 2007) 
CPV3 † Pigmented plaques, in situ SCC, 
invasive SCC 
(Tobler et al., 2006) 
(Lange et al., 2009) 
CPV4 † Pigmented plaques (Tanabe et al., 2000) 
(Narama et al., 2005) 
(Tobler et al., 2008) 
CPV5 † Pigmented plaques None 
CPV6 λ Inverted papillomas None 
CPV7 * Exophytic warts, in situ SCC None 
 408 
• Unnamed putative PV genus 1; † Unnamed putative PV genus 2 409 
410 
  
Figure 1  410 
 411 
 412 
 413 
 414 
 415 
 416 
Figure 1: Schematic presentation of the canine papillomavirus genomes and open 417 
reading frames (ORFs). The genomes are divided into three sections: early genes 418 
(Early), late genes (Late) and non-coding regions (NCRs). Numbers indicate 419 
nucleotide positions. Nucleotide position number one is set as the first following the 420 
stop codon of L1 ORFs.  421 
422 
  
Figure 2  422 
 423 
 424 
425 
  
 425 
Figure 2: Neighbour-joining phylogenetic tree of the L1 nucleotide sequences of 50 426 
papillomaviruses (PVs). To date unclassified PVs or/and putative PV genera are 427 
marked with an asterisk. The PV-types (with their GenBank accession numbers) 428 
included bovine BPV1 (NC_001522), BPV3 (NC_004197), BPV5 (NC_004195), 429 
BPV6 (AJ620208), bandicoot papillomatosis carcinomatosis BPCV1 (NC_010107), 430 
canine oral COPV (NC_001619), canine CPV2 (NC_006564), CPV3 (NC_008297), 431 
CPV4 (NC_010226), CPV5 (FJ492743), CPV6 (FJ492744), CPV7 (FJ492742), 432 
Capra hircus ChPV1 (NC_008032), Erethizon dorsatum EdPV1 (AY684126), Equus 433 
caballus EcPV1 (NC_003748), Fringilla coelebs FcPV1 (NC_004068), Felis 434 
domesticus FdPV1 (NC_004765), FdPV2 (EU796884), hamster oral HaPV1 435 
(E15111), human HPV1 (NC_001356), HPV3 (NC_001588), HPV4 (NC_001457), 436 
HPV5 (NC_001531), HPV9 (NC_001596), HPV12 (X74466), HPV13 (NC_001349), 437 
HPV14 (X74467), HPV15 (NC_001579), HPV16 (NC_001526), HPV17 (X74469), 438 
HPV18 (NC_001357), HPV20 (U31778), HPV21 (U31779), HPV32 (X74475), 439 
HPV41 (NC_001354), HPV50 (NC_001691), HPV63 (NC_001458), Lynx rufus 440 
LrPV1 (AY904722), Mastomys natalensis MnPV1 (NC_001605), Ovine OvPV1 441 
(NC_001789), Puma concolor PcPV1 (AY904723), Psittacus erithacus PePV1 442 
(NC_003973), Procyon lotor PlPV1 (AY763115), Panthera leo persica PlpPV1 443 
(AY904724), Phocoena spinipinnis PsPV1 (NC_003348), rabbit oral ROPV 444 
(NC_002232), Rousettus aeyptiacus RaPV1 (NC_008298), Trichechus manatus 445 
latirostris TmlPV1 (NC_006563), Ursus maritimus UmPV1 (NC_010739), Uncia 446 
uncia UuPV1 (DQ180494). Numbers at internal nodes represent the posterior 447 
probability support values. Only posterior probabilities above 0.5 are shown. 448 
449 
  
Figure S1 449 
Characteristic features on nucleotide and amino acid level 450 
 451 
A 452 
 453 
 
 
COPV CPV2 CPV3 CPV4 CPV5 CPV6 CPV7 
GC content 
 
42% 46% 51% 53% 50% 40% 46% 
 454 
 455 
B 456 
 457 
Predicted nt-feature 
 
COPV CPV2 CPV3 CPV4 CPV5 CPV6 CPV7 
E2 binding site 
(ACC-N6-GGT) 
203; 321 331; 434; 
3747; 5259 
116; 179;  
285; 325;  
416; 475;  
498; 1274; 
4501; 5460 
57; 124;  
314; 404;  
463; 487; 
4506; 5575 
107; 170;  
317; 406;  
465; 490; 
1270; 2217; 
4518; 4762;  
5624; 7088 
88; 252;  
320; 390;  
845; 2482; 
2616; 6233; 
6508 
156; 173; 
 327; 356;  
431; 2736; 
5070 
Dyad symmetry repeats * 
(TTGTTGTTAACAACAA) 
281 393 454 442 444 275 99; 390;  
667; 4532; 
7507 
 Poly adanylation sites 
(AATAAA) 
24; 5524; 
5637; 7055; 
7123 
3; 72; 310; 
5469; 6069; 
7621 
4850; 7800 4786; 4790; 
7741 
2499; 7809 17; 4036; 
4250; 5276; 
7136; 8179; 
8242 
59; 4512; 
4986; 6692; 
7271; 7954 
SP1 binding sites 
(GGCGGG) 
3824 5508 462 552; 3458; 
4889; 5116 
555 3455 1861; 5198 
NF1 binding sites 
(CGGAA) 
911; 825; 
1686; 2640; 
2771; 3098 
401; 969; 
2392; 3155; 
3914; 6775 
204; 230; 
301; 522; 
2408; 3408; 
3633 
209; 250;  
279; 510; 
1640; 2260; 
4572; 5840; 
6260 
195; 215;  
255; 360;  
514; 2407; 
2729; 3239; 
3629; 4166; 
4722; 5712 
155; 3949; 
4583; 6464; 
6535 
398; 3464; 
5264; 6626 
Tata signals 
(TATAAA or 
TATA(A/T)A(A/T)) 
354; 1882; 
2155; 6599; 
7255; 8133 
192; 449; 
3518; 4547; 
4555; 4642 
174 429;  
6088 
2722 348; 1897; 
2170; 4437; 
4484; 4627; 
4838; 7450 
38; 448; 
1732; 3203; 
3512 
 458 
* Modified in all cases but CPV3 and CPV4 459 
Underlined starting positions are part of the putative origin of replication 460 
 461 
C 462 
 463 
Predicted aa-feature 
 
COPV CPV2 CPV3 CPV4 CPV5 CPV6 CPV7 
ATP-dependent helicase motifs 
in E1 † (GPPNTGKS) 
426aa/ 
2356nt 
437aa/ 
2494nt  
456aa/ 
2642nt  
457aa/ 
2632nt 
457aa/ 
2641nt  
431aa/ 
2365nt 
434aa/ 
2485nt  
metal-binding motifs in E6 ‡ 
(CX2CX29CX2C) 
33aa/ 460nt 
106aa/679nt 
25aa/ 568nt 
98aa/ 787nt 
25aa/ 642nt 
98aa/ 861nt 
25aa/ 632nt 
98aa/ 851nt 
25aa/ 635nt 
98aa/ 854nt 
25aa/ 460nt 
98aa/679nt 
25aa/ 560nt 
98aa/ 779nt 
metal-binding motifs in E7 ‡ § 
(CX2CX29CX2C) 
52aa/ 948nt 50aa/ 
1035nt 
59aa/ 
1144nt 
53aa/ 
1131nt 
54aa/ 
1140nt 
52aa/ 945nt 50aa/ 
1053nt 
pRb binding domain in E7 
(LXCXE) 
22aa/ 858nt - 28aa/ 
1051nt 
23aa/ 
1041nt 
23aa/ 
1047nt 
24aa/ 861nt - 
 464 
† Modified (GPPDTGKS) in all cases but COPV, CPV4 and CPV6 465 
‡ Modified (CX2CX28CX2C) in case of COPV and CPV6 466 
§ Modified (CX2CX30CX2C) in case of CPV2 and CPV7 467 
468 
  
Figure S2 468 
 469 
 470 
 471 
 472 
 473 
 474 
Figure S2: Box plot analysis comparing the distribution of genome sizes among the 475 
HPV genera Alpha (HPVs 2, 3, 6, 7, 10, 11, 13, 16, 18, 26, 27, 28, 29, 30, 31, 32, 33, 476 
34, 35, 39, 40, 42, 43, 44, 45, 52, 53, 54, 55, 56, 57, 58, 59, 61, 62, 66, 67, 68, 69, 70, 477 
71, 72, 73, 74, 77, 81, 82, 83, 84, 90, 94, 97, 102, 106), Beta (HPVs 5, 8, 9, 12, 14, 478 
15, 17, 19, 20, 21, 22, 23, 24, 25, 36, 37, 38, 47, 49, 75, 76, 80, 92, 93, 96, 98, 99, 479 
100, 104, 105, 107, 109, 110, 111, 113) and Gamma (HPVs 4, 48, 50, 65, 88, 95, 101, 480 
103, 108, 112). The differences among the genera proved significant (P < 0.05) in 481 
Bonferroni test (PRISM, GraphPad Software). 482 
 483 
